SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-099450
Filing Date
2024-09-12
Accepted
2024-09-12 21:36:34
Documents
2
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2423876-6_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2423876-6_3seq1.xml 3 2912
2 EXHIBIT 24 tm2423876d6_ex24.htm EX-24 7833
  Complete submission text file 0001104659-24-099450.txt   12329
Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC 200 SMITH STREET WALTHAM MA 02451
Business Address 978-687-6988
Allen Patricia L (Reporting) CIK: 0001348587 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42270 | Film No.: 241296306

Mailing Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451
Business Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Issuer) CIK: 0001953926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)